Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3

• Published in: Frontiers in oncology Vol. 10; p. 1108
• Main Authors: Li, Junhua, Li, Qingjian, Li, Danhua, Shen, Zhiwen, Zhang, Kun, Bi, Zhuofei, Li, Yujuan
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 10-07-2020
• Subjects: JAK/Stat3 signaling pathway; long non-coding RNA; MNX1-AS1; Oncology; signal transducers and activators of transcription; triple negative breast cancer
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2020.01108

Triple negative breast cancer (TNBC) accounts for less than a quarter of breast cancer but has the poorest survival outcome and is prone to relapse as well as metastasis due to its aggressiveness and lack of therapeutic target. Herein, we analyzed the TCGA datasets of lncRNA expressional profiles of breast cancer vs. normal tissue and TNBC vs. Non-TNBC subtypes and screened a long non-coding RNA (lncRNA) MNX1-AS1 overexpressing in TNBC. We found that MNX1-AS1 were upregulated in TNBC tumor tissues and correlated with poor survival outcome in TNBC patients. Silencing MNX1-AS1 reduced the aggressiveness of TNBC
in vitro
and
in vivo
. By using RNA pulldown assay followed by western blotting and RNA immunoprecipitation (RIP), we identified Stat3 was the MNX1-AS1 binding protein and MNX1-AS1 upregulated the phosphorylation of Stat3 by enhancing the interaction between p-JAK and Stat3. The present study suggested that targeting MNX1-AS1 may represent a promising therapeutic strategy to TNBC.